School of Medicine
Showing 1,171-1,180 of 1,599 Results
-
Sushma Reddy
Associate Professor of Pediatrics (Cardiology)
Current Research and Scholarly InterestsMy laboratory's expertise in cardiovascular phenotyping has led to the development of mouse models of congenital heart disease that recapitulate abnormal loading conditions on the heart. We have used these models to advance our understanding of the mechanisms of right heart failure in children and adults with congenital heart disease with the long term goal of identifying noninvasive diagnostic tools to better assess right ventricular health and to develop right ventricle specific therapeutics.
-
Shobha Regmi
Research Scientist, Pediatrics - Gastroenterology
BioDr. Regmi earned her PhD in Pharmacy from Yeungnam University, South Korea. Before joining us, she was a postdoctoral fellow in the Department of Radiology under the mentorship of Dr. Avnesh S. Thakor. With over a decade of experience researching novel therapies for inflammatory diseases and expertise in cell therapy, Dr. Regmi brings valuable skills in in vivo and in vitro experimental biology, immunology, complex multicolor flow cytometry, and scientific writing. Her expertise will be instrumental in advancing the Rosen Lab’s research on the molecular mechanisms underlying pediatric IBD and treatment response.
Dr. Regmi’s work will focus on investigating the role of stromal-immune crosstalk that drives ulcerative colitis. -
David Rehkopf
Director, Stanford Center on Longevity, Professor of Epidemiology and Population Health, of Sociology, of Medicine (Primary Care and Population Health) and, by courtesy, of Pediatrics, and of Health Policy
BioI am a social epidemiologist and serve as a Professor in the Department of Epidemiology and Population Health and in the Department of Medicine in the Division of Primary Care and Population Health. I joined the faculty at Stanford School of Medicine in 2011.
I am Director of the Stanford Center for Population Health Sciences. In this position, I am committed to making high-value data resources available to researchers across disciplines in order to better enable them to answer their most pressing clinical and population health questions.
My own research is focused on understanding the health implications of the myriad decisions that are made by corporations and governments every day - decisions that profoundly shape the social and economic worlds in which we live and work. While these changes are often invisible to us on a daily basis, these seemingly minor actions and decisions form structural nudges that can create better or worse health at a population level. My work demonstrates the health implications of corporate and governmental decisions that can give the public and policy makers evidence to support new strategies for promoting health and well-being. In all of his work, I have a focus on the implications of these exposures for health inequalities.
Since often policy and programmatic changes can take decades to influence health, my work also includes more basic research in understanding biological signals that may act as early warning signs of systemic disease, in particular accelerated aging. I examine how social and economic policy changes influence a range of early markers of disease and aging, with a particular recent focus on DNA methylation. I am supported by several grants from the National Institute on Aging and the National Institute on Minority Health and Health Disparities to develop new more sensitive ways to understand the health implications of social and economic policy changes. -
Jenna Reisler
Affiliate, Department Professorship Funds
Fellow in Peds/Clinical InformaticsBioJenna Reisler, MD is an Internal Medicine-trained Clinical Informatics Fellow passionate about designing clinical decision support tools that reduce clinician burden and improve patient outcomes. Her work spans AI-integrated CDS for falls prevention, human-centered EHR workflow design, and quality improvement in ambulatory care. Recent projects include a co-investigator role on an EPIC-based falls prevention CDS tool published in Applied Clinical Informatics, and co-PI of an ACGME Back to Bedside–funded home visit program integrating social determinants of health into residency training.
-
David A. Relman
Thomas C. and Joan M. Merigan Professor and Professor of Microbiology and Immunology
Current Research and Scholarly InterestsMy investigative program focuses on human-microbe interactions and human microbial ecology, and primarily concerns the ecology of human indigenous microbial communities; a secondary interest concerns the classification of humans with systemic infectious diseases, based on features of genome-wide gene transcript abundance patterns and pther aspects of the host response.
-
Chloe Reuter
Clinical Associate Professor, Medicine - Cardiovascular Medicine
Clinical Associate Professor, Pediatrics - Medical GeneticsBioChloe Reuter is a Genetic Counselor and Clinical Associate Professor in the Division of Cardiovascular Medicine at Stanford University School of Medicine. She is Principal Investigator of an NIH-funded research program focused on developing frameworks for the clinical translation of multi-omic technologies in rare diseases.
Ms. Reuter provides genetic counseling care at the Stanford Center for Inherited Cardiovascular Diseases, specializing in inherited cardiovascular conditions including cardiomyopathies, arrhythmia syndromes, and sudden cardiac death. She has expertise in interpreting complex genomic results from multi-gene panels, exome sequencing, and whole genome sequencing for patients with rare and undiagnosed diseases.
Ms. Reuter's research centers on translating cutting-edge genomic technologies into clinical practice. She develops frameworks for integrating multi-omic data (genomic, transcriptomic, and other omics) into diagnostic workflows and contributes to evidence-based guidelines for variant interpretation and clinical curation. Her work addresses the ethical and practical challenges of implementing these technologies, with particular focus on patient engagement, equitable access to precision medicine, and protocols for returning complex research results. She also conducts genetic counseling practice research, examining patient experiences, psychosocial assessment tools, and healthcare delivery models including telehealth services.
She has contributed to multiple national genomics initiatives including the Undiagnosed Diseases Network and the GREGoR Consortium, applying comprehensive genomic approaches to solve medical mysteries and improve diagnostic outcomes for patients with rare diseases.
